Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy

NCT03017794 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03017794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03017794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Active, not recruiting
Start date
January 4, 2017
Completion date
December 31, 2027
Enrollment
118 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer